close

Fundraisings and IPOs

Date: 2011-11-14

Type of information: Fundraising

Company: Azellon Cell Therapeutics (UK)

Investors: IP Group (UK) - Oxford Technology Management (UK) - Hugh Osmond

Amount: £0.65 million

Funding type:

Planned used:

Others:

* On November 14, 2011, Azellon Cell Therapeutics, a developer of a stem cell therapy for the repair of torn meniscal cartilage, has announced it has successfully completed a £0.65 million financing round that was required to take its pioneering stem cell bandage into human clinical trials and for related commercial activities.

Therapeutic area: Regenerative medicine

Is general: Yes